NEW YORK (GenomeWeb) – The National Institutes of Health announced that it will commit $3.5 million to fund research identifying and developing biomarkers for Lewy body dementias (LBDs).

LBDs comprise two related neurodegenerative disorders characterized by the abnormal accumulation of alpha-synuclein in the brain — dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD). The conditions primarily differ in the timing of the onset of cognitive and movement symptoms. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.